Psychopharmacology
... Nicotinic receptor: • An ionotropic acetylcholine receptor that is stimulated by nicotine and blocked by curare. Muscarinic receptor: • A metabotropic acetylcholine receptor that is stimulated by muscarine and blocked by ...
... Nicotinic receptor: • An ionotropic acetylcholine receptor that is stimulated by nicotine and blocked by curare. Muscarinic receptor: • A metabotropic acetylcholine receptor that is stimulated by muscarine and blocked by ...
Pharmacological treatment of schizophrenia–a review of progress
... reviewed available data derived from brain studies) and is one of the most popular target systems for drug development in schizophrenia. The noradrenergic theory of schizophrenia has its basis on the observation that locus coeruleus noradrenaline neurons can affect executive and cognitive function ...
... reviewed available data derived from brain studies) and is one of the most popular target systems for drug development in schizophrenia. The noradrenergic theory of schizophrenia has its basis on the observation that locus coeruleus noradrenaline neurons can affect executive and cognitive function ...
Atropine
... rate), asystole and pulseless electrical activity (PEA) in cardiac arrest. This works because the main action of the vagus nerve of the parasympathetic system on the heart is to decrease heart rate. Atropine blocks this action and, therefore, may speed up the heart rate. However, in the latest guide ...
... rate), asystole and pulseless electrical activity (PEA) in cardiac arrest. This works because the main action of the vagus nerve of the parasympathetic system on the heart is to decrease heart rate. Atropine blocks this action and, therefore, may speed up the heart rate. However, in the latest guide ...
Muscarinic antagonist
... rate), asystole and pulseless electrical activity (PEA) in cardiac arrest. This works because the main action of the vagus nerve of the parasympathetic system on the heart is to decrease heart rate. Atropine blocks this action and, therefore, may speed up the heart rate. However, in the latest guide ...
... rate), asystole and pulseless electrical activity (PEA) in cardiac arrest. This works because the main action of the vagus nerve of the parasympathetic system on the heart is to decrease heart rate. Atropine blocks this action and, therefore, may speed up the heart rate. However, in the latest guide ...
The statin class of HMGA CoA reductase inhibitors demonstrate
... compounds, again sharing structural similarities, such as a common fluoride side group (Figure 1). In general, statins are administered in their active form, and are readily absorbed by passive diffusion. However, both simvastatin and lovastatin are administered as inactive lactone prodrugs, which a ...
... compounds, again sharing structural similarities, such as a common fluoride side group (Figure 1). In general, statins are administered in their active form, and are readily absorbed by passive diffusion. However, both simvastatin and lovastatin are administered as inactive lactone prodrugs, which a ...
Hydrophobic interactions of phenoxazine modulators with bovine
... experiments. The experiments were performed on a 20 × 1⋅3 cm column of sephadexR G50 fine (Pharmacia) at 22°C, equilibrated with standard buffer solution. The flow rate was maintained at 25 ml/h. BSA solution (20 ml, 1%) containing 1⋅0 × 10–4 M phenoxazine modulator, after incubation at 37°C for 6 h ...
... experiments. The experiments were performed on a 20 × 1⋅3 cm column of sephadexR G50 fine (Pharmacia) at 22°C, equilibrated with standard buffer solution. The flow rate was maintained at 25 ml/h. BSA solution (20 ml, 1%) containing 1⋅0 × 10–4 M phenoxazine modulator, after incubation at 37°C for 6 h ...
Volume 48 Number 4
... ASPET continues its leading advocacy to increase training for integrative organ systems pharmacology. ASPET is also committed to making significant contributions through its new affiliation with The FDA Alliance to increase funding for the agency, and as always, we are continuing to work in partners ...
... ASPET continues its leading advocacy to increase training for integrative organ systems pharmacology. ASPET is also committed to making significant contributions through its new affiliation with The FDA Alliance to increase funding for the agency, and as always, we are continuing to work in partners ...
Spectrophotometric Determination of Lorsartan Potassium
... and phosphate buffer solution (pH 3-4) as a diluting agent was developed. The developed colour shows maximum absorbance at 620 nm and it was observed that the absorbance of different dilution from the plots the calibration curve between the concentrations in x-axis, absorbance at y-axis. The recover ...
... and phosphate buffer solution (pH 3-4) as a diluting agent was developed. The developed colour shows maximum absorbance at 620 nm and it was observed that the absorbance of different dilution from the plots the calibration curve between the concentrations in x-axis, absorbance at y-axis. The recover ...
Reversible and regionally selective downregulation of brain
... cannabis smokers than in healthy subjects in cortical, but not in subcortical brain regions. VT was also negatively correlated with years of cannabis smoking: subjects who had smoked cannabis longer had lower VT than subjects who had smoked for a shorter time. Finally, VT increased in cannabis smoke ...
... cannabis smokers than in healthy subjects in cortical, but not in subcortical brain regions. VT was also negatively correlated with years of cannabis smoking: subjects who had smoked cannabis longer had lower VT than subjects who had smoked for a shorter time. Finally, VT increased in cannabis smoke ...